Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management. Ticker symbol: ASRT
| Website | https://www.assertiotx.com |
| Revenue | $125.8 million |
| Employees | 64 (49 on RocketReach) |
| Founded | 1995 |
| Address | 100 South Saunders Road, 300, Lake Forest, Illinois 60045, US |
| Industry | Pharmaceutical Manufacturing, Drug Discovery, Neurology, Biotechnology, Specialty Pharmaceuticals |
| Keywords | Central Nervous System, Neurology Drugs, Pharmaceutical Research, Drug Development, Clinical Trials, Prescription Drugs, Analgesics, Opioid Alternatives, Non-Opioid Pain Relief, Novel Therapies, Innovative Medicines, Healthcare, Biopharma, Therapeutics, Biotechnology, Pharmaceutical, Medicine, Health, Treatment |
Looking for a particular Assertio Therapeutics, Inc. employee's phone or email?
The Assertio Therapeutics, Inc. annual revenue was $125.8 million in 2026.
Paul Schwichtenberg is the President and Chief Operating Officer of Assertio Therapeutics, Inc..
49 people are employed at Assertio Therapeutics, Inc..
Assertio Therapeutics, Inc. is based in Lake Forest, Illinois.